Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2020 May 6

PMID 32368023

Citations 9

Authors

Ewa Zasadzka

Anna Pieczynska

Tomasz Trzmiel

Mariola Pawlaczyk

Affiliations

Soon will be listed here.

Abstract

Introduction: Completion of the SARC-F questionnaire constitutes the obligatory first step in the diagnostic process of sarcopenia, according to the revised European consensus on the definition and diagnosis of sarcopenia published by the European Working Group on Sarcopenia in Older People2 (EWGSOP2). SARC-F has been recognized as the most up-to-date and coherent screening tool for sarcopenia. The aim of the study was to translate and to validate the Polish version of the SARC-F questionnaire.

Materials And Methods: The validation process was performed in two stages: 1) translation and intercultural adaptation and 2) clinical validation. The inclusion criteria were as follows: age ≥65 years, unimpaired mobility, and no cognitive impairment. The EWGSOP2 criteria were used to diagnose sarcopenia. Hand grip strength measurement, physical fitness test, and body weight composition analysis were conducted. Sensitivity, specificity, accuracy-likelihood ratios, and SARC-F predictive values were calculated using the EWGSOP2 criteria.

Results: Sixty-seven people participated in the study of whom 21% were diagnosed with sarcopenia (SARC-F score: ≥4). The reliability of the questionnaire based on the Cronbach's alpha coefficient was 0.784. Sensitivity, specificity, and negative predictive values were 92.9%, 98.1%, and 98.1%, respectively.

Conclusion: The process of validating the SARC-F questionnaire against Polish conditions demonstrated its applicability as a simple and reliable tool for diagnosing sarcopenia in daily clinical practice with older adults.

Citing Articles

SARC-F: an effective screening tool for detecting sarcopenia and predicting health-related quality of life in older women in Sri Lanka.

Rathnayake N, Abeygunasekara T, Liyanage G, Subasinghe S, De Zoysa W, Palangasinghe D BMC Geriatr. 2025; 25(1):129.

PMID: 40000973 PMC: 11853872. DOI: 10.1186/s12877-025-05786-z.

Agreement analysis and associated factors of SARC-F and SARC-CALF in screening of risk sarcopenia in people living with human immunodeficiency virus.

Vieira L, Ximenez J, Spexoto M Clinics (Sao Paulo). 2025; 80():100565.

PMID: 39752996 PMC: 11754822. DOI: 10.1016/j.clinsp.2024.100565.

Insights into geriatric health: primary sarcopenia and innate immunity dynamics, examining SARC-F, serum TLR 4, TLR 9, and resolvin levels.

Bilgin S, Suzan V, Avci S, Yavuzer H, Bolayirli I, Doventas A Intern Emerg Med. 2024; 19(7):1867-1875.

PMID: 38910224 PMC: 11467011. DOI: 10.1007/s11739-024-03678-5.

Comparison of six screening methods for sarcopenia among rural community-dwelling older adults: a diagnostic accuracy study.

Peng Y, Zhang L, Kong Y, Zhang X, Li Z, Jia H Eur Geriatr Med. 2024; 15(3):681-688.

PMID: 38451402 DOI: 10.1007/s41999-024-00955-6.

Symptoms of Sarcopenia and Physical Fitness through the Senior Fitness Test.

de Lima A, Baptista F, Henrinques-Neto D, Pinto A, Gouveia E Int J Environ Res Public Health. 2023; 20(3).

PMID: 36768077 PMC: 9915373. DOI: 10.3390/ijerph20032711.

References

Kera T, Kawai H, Hirano H, Kojima M, Watanabe Y, Motokawa K . SARC-F: A validation study with community-dwelling older Japanese adults. Geriatr Gerontol Int. 2019; 19(11):1172-1178. DOI: 10.1111/ggi.13768. View

Malmstrom T, Miller D, Simonsick E, Ferrucci L, Morley J . SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016; 7(1):28-36. PMC: 4799853. DOI: 10.1002/jcsm.12048. View

Woo J, Leung J, Morley J . Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2014; 16(3):247-52. DOI: 10.1016/j.jamda.2014.11.013. View

Lawton M, Brody E . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9(3):179-86. View

Borson S, Scanlan J, BRUSH M, Vitaliano P, Dokmak A . The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000; 15(11):1021-7. DOI: 10.1002/1099-1166(200011)15:11<1021::aid-gps234>3.0.co;2-6. View

Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View

Bahat G, Yilmaz O, Oren M, Karan M, Reginster J, Bruyere O . Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group. Eur Geriatr Med. 2021; 9(1):23-28. DOI: 10.1007/s41999-017-0003-5. View

Cruz-Jentoft A, Baeyens J, Bauer J, Boirie Y, Cederholm T, Landi F . Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39(4):412-23. PMC: 2886201. DOI: 10.1093/ageing/afq034. View

Rosenberg I, Roubenoff R . Stalking sarcopenia. Ann Intern Med. 1995; 123(9):727-8. DOI: 10.7326/0003-4819-123-9-199511010-00014. View

10.

Davidson P, DiGiacomo M, McGrath S . The feminization of aging: how will this impact on health outcomes and services?. Health Care Women Int. 2011; 32(12):1031-45. DOI: 10.1080/07399332.2011.610539. View

11.

Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T . Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int. 2014; 14 Suppl 1:93-101. DOI: 10.1111/ggi.12197. View

12.

Brown J, Harhay M, Harhay M . Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016; 7(3):290-8. PMC: 4864252. DOI: 10.1002/jcsm.12073. View

13.

Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez A, Malmstrom T, Cruz-Arenas E, Rosas-Carrasco O . Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc. 2016; 17(12):1142-1146. DOI: 10.1016/j.jamda.2016.09.008. View

14.

Vellas B, Fielding R, Bens C, Bernabei R, Cawthon P, Cederholm T . Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging. 2018; 7(1):2-9. DOI: 10.14283/jfa.2017.30. View

15.

Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M . Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia. Int J Environ Res Public Health. 2017; 14(7). PMC: 5551247. DOI: 10.3390/ijerph14070809. View

16.

Barbosa-Silva T, Menezes A, Bielemann R, Malmstrom T, Gonzalez M . Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc. 2016; 17(12):1136-1141. DOI: 10.1016/j.jamda.2016.08.004. View

17.

Cao L, Chen S, Zou C, Ding X, Gao L, Liao Z . A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging. 2014; 18(3):277-83. DOI: 10.1007/s12603-013-0410-3. View

18.

Katz S, Downs T, CASH H, Grotz R . Progress in development of the index of ADL. Gerontologist. 1970; 10(1):20-30. DOI: 10.1093/geront/10.1_part_1.20. View

19.

Sanchez-Rodriguez D, Marco E, Davalos-Yerovi V, Lopez-Escobar J, Messaggi-Sartor M, Barrera C . Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People. J Nutr Health Aging. 2019; 23(6):518-524. DOI: 10.1007/s12603-019-1204-z. View

20.

Yesavage J, Brink T, Rose T, Lum O, Huang V, Adey M . Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982; 17(1):37-49. DOI: 10.1016/0022-3956(82)90033-4. View